Cargando…

Effect of anticoagulation therapy in older patients with chronic kidney disease and atrial fibrillation: A meta-analysis

BACKGROUND: The role of anticoagulation therapy for stroke prevention in older atrial fibrillation (AF) patients with chronic kidney disease (CKD) remains unclear. Therefore, we conducted a meta-analysis to explore the efficacy and safety of anticoagulation therapy in this population. METHODS: The C...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Wenfeng, Zhang, Hao, Zhu, Wengen, Xue, Zhengbiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	3400
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824694/ https://www.ncbi.nlm.nih.gov/pubmed/31626146 http://dx.doi.org/10.1097/MD.0000000000017628

Ejemplares similares

Meta-analysis of the efficacy and safety of non-vitamin K antagonist oral anticoagulants with warfarin in Latin American patients with atrial fibrillation
por: Su, Zhiyu, et al.
Publicado: (2020)

Relationship between psychological factors and atrial fibrillation: A meta-analysis and systematic review
por: Fu, Yonghui, et al.
Publicado: (2020)

Efficacy and Safety of Oral Anticoagulants Versus Aspirin for Patients With Atrial Fibrillation: A Meta-Analysis
por: Zhang, Jing-Tao, et al.
Publicado: (2015)

Resuming anticoagulation in patients with atrial fibrillation experiencing intracranial hemorrhage
por: Wu, Victor Chien-Chia, et al.
Publicado: (2021)

The impact of renal function on efficacy and safety of new oral anticoagulant in atrial fibrillation patients: A systemic review and meta-analysis
por: Gui, Yi-yue, et al.
Publicado: (2019)

The effect of concomitant chronic kidney disease on the recurrence of atrial fibrillation after catheter ablation: A protocol for systematic review and meta-analysis
por: Liu, Xiaodong, et al.
Publicado: (2021)

Comparison of the effects of left atrial appendage closure and oral anticoagulants in preventing stroke in patients with non-valvular atrial fibrillation: A protocol for systematic review and meta-analysis
por: Yue, Deyong, et al.
Publicado: (2021)

It can be safe to discontinue oral anticoagulants after successful atrial fibrillation ablation: A systematic review and meta-analysis of cohort studies
por: Wang, Xiangyu, et al.
Publicado: (2023)

Comparing the clinical outcomes in patients with atrial fibrillation receiving dual antiplatelet therapy and patients receiving an addition of an anticoagulant after coronary stent implantation: A systematic review and meta-analysis of observational studies
por: Chaudhary, Nabin, et al.
Publicado: (2016)

Is ablation to atrial fibrillation termination of persistent atrial fibrillation the end point?: A systematic review and meta-analysis
por: Li, Fanghui, et al.
Publicado: (2019)

Chronic kidney disease and cardiovascular mortality in patients with atrial fibrillation: European Society of Hypertension project – ESH A Fib
por: Premužić, Vedran, et al.
Publicado: (2021)

Is the Risk of Diabetes Lower in Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulant Compared to Warfarin?
por: Liu, Xuyang, et al.
Publicado: (2022)

The role of non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation: A PRISMA-compliant article
por: Liu, Xuyang, et al.
Publicado: (2020)

Digoxin Use and Adverse Outcomes in Patients With Atrial Fibrillation
por: Zeng, Wu-Tao, et al.
Publicado: (2016)

Increased All-Cause Mortality Associated With Digoxin Therapy in Patients With Atrial Fibrillation: An Updated Meta-Analysis
por: Chen, Ying, et al.
Publicado: (2015)

Management of stable coronary artery disease and atrial fibrillation with anti-thrombotic therapy: A systematic review and meta-analysis
por: Malladi, Srikanth, et al.
Publicado: (2021)

Mitral annular calcification is associated with atrial fibrillation and major cardiac adverse events in atrial fibrillation patients: A systematic review and meta-analysis
por: Li, Yimin, et al.
Publicado: (2019)

Association of Depression, Antidepressants With Atrial Fibrillation Risk: A Systemic Review and Meta-Analysis
por: Fu, Yonghui, et al.
Publicado: (2022)

Ranolazine in the prevention and treatment of atrial fibrillation: A protocol for meta-analysis
por: Yuan, Chengdai, et al.
Publicado: (2021)

Effectiveness and Safety of Warfarin in Dialysis Patients With Atrial Fibrillation: A Meta-Analysis of Observational Studies
por: Liu, Gang, et al.
Publicado: (2015)

Comparison of HAS-BLED with other risk models for predicting the bleeding risk in anticoagulated patients with atrial fibrillation: A PRISMA-compliant article
por: Zeng, Junquan, et al.
Publicado: (2020)

Does the CHA(2)DS(2)-VASc scale sufficiently predict the risk of left atrial appendage thrombus in patients with diagnosed atrial fibrillation treated with non-vitamin K oral anticoagulants?
por: Michalska, Anna, et al.
Publicado: (2020)

Efficacy and safety of vernakalant for cardioversion of recent-onset atrial fibrillation: A protocol for systematic review and meta-analysis
por: Li, Hong, et al.
Publicado: (2022)

A meta-analysis for efficacy and safety evaluation of transcatheter left atrial appendage occlusion in patients with nonvalvular atrial fibrillation
por: Wei, Zhonghai, et al.
Publicado: (2016)

Traditional Chinese exercise for non-valvular atrial fibrillation: A protocol for systematic review and meta-analysis
por: Wang, Te, et al.
Publicado: (2022)

Upregulated miR-328-3p and its high risk in atrial fibrillation: A systematic review and meta-analysis with meta-regression
por: Huang, Haitao, et al.
Publicado: (2022)

Left atrial deformation and risk of transient ischemic attack and stroke in patients with paroxysmal atrial fibrillation
por: Chen, Jian, et al.
Publicado: (2023)

Oncostatin M was associated with thrombosis in patients with atrial fibrillation
por: Xie, Jun, et al.
Publicado: (2017)

Double antithrombotic therapy for prevention of bleeding and ischemic events after percutaneous coronary intervention in patients with atrial fibrillation: A meta-analysis
por: Qiu, Mei, et al.
Publicado: (2021)

Natriuretic peptides as predictors for atrial fibrillation recurrence after catheter ablation: A meta-analysis
por: Yuan, Yujing, et al.
Publicado: (2023)

Indonesian registry on atrial fibrillation (OneAF)
por: Raharjo, Sunu Budhi, et al.
Publicado: (2021)

Paraoxonase 1 and atrial fibrillation: Is there a relationship?
por: Istratoaie, Sabina, et al.
Publicado: (2022)

Effects of continuous positive airway pressure treatment in obstructive sleep apnea patients with atrial fibrillation: A meta-analysis
por: Li, Xinyao, et al.
Publicado: (2021)

Left atrial wall dyskinesia assessed during contractile phase as a predictor of atrial fibrillation recurrence after electrical cardioversion performed due to persistent atrial fibrillation
por: Wałek, Paweł, et al.
Publicado: (2020)

Editorial: Effects of oral anticoagulant therapy in atrial fibrillation patients with comorbidities
por: Li, Runkai, et al.
Publicado: (2023)

Echocardiographic assessment of left atrial function for prediction of efficacy of catheter ablation for atrial fibrillation
por: Pilichowska-Paszkiet, Ewa, et al.
Publicado: (2021)

Direct Oral Anticoagulants vs. Warfarin in Latin American Patients With Atrial Fibrillation: Evidence From Four post-hoc Analyses of Randomized Clinical Trials
por: Liu, Fuwei, et al.
Publicado: (2022)

Comparison of radiofrequency ablation and antiarrhythmic drug for the treatment of atrial fibrillation: A protocol for systematic review and meta-analysis
por: Deng, Junping, et al.
Publicado: (2022)

Atrioesophageal fistula after atrial fibrillation catheter ablation: A case report
por: He, Fan, et al.
Publicado: (2021)

Fluoroquinolones increase the risk of serious arrhythmias: A systematic review and meta-analysis
por: Liu, Xiao, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_if18nsoi3he8nld8vvbmoed1me